BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29708949)

  • 1. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in renal cell carcinoma.
    D'Avella C; Abbosh P; Pal SK; Geynisman DM
    Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
    Williamson SR; Gill AJ; Argani P; Chen YB; Egevad L; Kristiansen G; Grignon DJ; Hes O
    Am J Surg Pathol; 2020 Jul; 44(7):e47-e65. PubMed ID: 32251007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
    Liu YJ; Houldsworth J; Emmadi R; Dyer L; Wolff DJ
    Cancer Genet; 2020 Jun; 244():40-54. PubMed ID: 32434132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
    Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
    Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; RouprĂȘt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic alterations and diagnosis of renal cancer.
    Zhang X; Bolck HA; Rupp NJ; Moch H
    Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a genome-based treatment landscape for renal cell carcinoma.
    Massari F; Di Nunno V; Santoni M; Gatto L; Caserta C; Morelli F; Zafarana E; Carrozza F; Mosca A; Mollica V; Iacovelli R; Sabbatini R; Porta C; Bracarda S
    Crit Rev Oncol Hematol; 2019 Oct; 142():141-152. PubMed ID: 31401421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine from the renal cancer genome.
    Riazalhosseini Y; Lathrop M
    Nat Rev Nephrol; 2016 Nov; 12(11):655-666. PubMed ID: 27694978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects.
    Kuroda N; Karashima T; Inoue K; Kasajima A; Ohe C; Kawakami F; Mikami S; Matsuura K; Moriyama M; Nagashima Y; Petersson F; Lopez JI; Cohen RJ; Michal M; Hes O
    Pol J Pathol; 2015 Mar; 66(1):3-8. PubMed ID: 26017874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management.
    Silagy AW; Sanchez A; Manley BJ; Bensalah K; Bex A; Karam JA; Ljungberg B; Shuch B; Hakimi AA
    Eur Urol Focus; 2019 Nov; 5(6):949-957. PubMed ID: 31040082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology.
    Su D; Singer EA; Srinivasan R
    Curr Opin Oncol; 2015 May; 27(3):217-23. PubMed ID: 25811348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
    Linehan WM; Ricketts CJ
    Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancillary studies in fine needle aspiration of the kidney.
    Renshaw AA; Gould EW
    Cancer Cytopathol; 2018 Aug; 126 Suppl 8():711-723. PubMed ID: 30156770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in the molecular classification of renal neoplasms.
    Young AN; Master VA; Amin MB
    ScientificWorldJournal; 2006 Dec; 6():2505-18. PubMed ID: 17619725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Entities in Renal Neoplasia.
    Mehra R; Smith SC; Divatia M; Amin MB
    Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Liu W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
    Cell Rep; 2018 Apr; 23(1):313-326.e5. PubMed ID: 29617669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards individualized therapy for metastatic renal cell carcinoma.
    Kotecha RR; Motzer RJ; Voss MH
    Nat Rev Clin Oncol; 2019 Oct; 16(10):621-633. PubMed ID: 30992569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.